Jefferies Group LLC Seres Therapeutics, Inc. Transaction History

Jefferies Group LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $416,222 - $584,032	-66,067 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$6.02 - $11.43 $370,031 - $702,567	61,467 Added 1336.24%	66,067 $240,000
Q2 2019 Aug 14, 2019	SELL	$2.28 - $7.35 $45,511 - $146,713	-19,961 Reduced 81.27%	4,600 $15,000
Q1 2019 May 15, 2019	SELL	$4.83 - $7.21 $9,177 - $13,699	-1,900 Reduced 7.18%	24,561 $169,000
Q4 2018 Feb 14, 2019	BUY	$4.52 - $8.88 $22,767 - $44,728	5,037 Added 23.51%	26,461 $120,000
Q3 2018 Nov 14, 2018	BUY	$7.33 - $9.23 $67,545 - $85,054	9,215 Added 75.48%	21,424 $163,000
Q2 2018 Aug 14, 2018	BUY	$6.91 - $9.55 $84,364 - $116,595	12,209 New	12,209 $105,000

46.3M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $114M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.